Athira Pharma to Implement 10-for-1 Reverse Stock Split to Boost Share Price and Meet Nasdaq Listing Requirements.
ByAinvest
Thursday, Sep 11, 2025 9:03 am ET1min read
ATHA--
Athira Pharma will effect a 10-for-1 reverse stock split to comply with Nasdaq's $1 minimum bid price requirement. The split will become effective on September 17, 2025, and trading will begin on September 18, 2025. The total number of authorized shares will be reduced from 900 million to 90 million, and the par value per share will remain at $0.0001. Proportional adjustments will be made to outstanding options, restricted stock units, and equity incentive plans.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet